Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma

NCT06919939 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma
Relapse

Interventions

DRUG: Epcoritamab
DRUG: Loncastuximab Tesirine

Sponsor

University of Miami

Collaborators

[object Object]
[object Object]